IL-1 stimulates ceramide accumulation without inducing apoptosis in intestinal epithelial cells

Fadia R Homaidan1, Marwan E El-Sabban, Iman Chakroun

  • 1Department of Physiology, Faculty of Medicine, American University of Beirut, Lebanon. fh01@aub.edu.lb

Insights

Interleukin-1 (IL-1) increases ceramide in inflammatory bowel disease (IBD) cells, but does not cause cell death. This suggests ceramide may contribute to increased tumor risk in IBD patients.

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Molecular Biology

Background:

  • Elevated cytokine levels, including interleukin-1 (IL-1), are characteristic of inflammatory bowel disease (IBD).
  • Previous research demonstrated IL-1 activates phospholipid signaling pathways in intestinal epithelial cells (IEC), leading to increased ceramide levels.

Purpose of the Study:

  • To investigate whether ceramide induces apoptosis in intestinal epithelial cells (IEC).

Main Methods:

  • Apoptosis was assessed using annexin-V binding and Hoechst nuclear staining.
  • Western blotting was employed to quantify levels of apoptosis-related proteins (bcl-2, bcl-x, bax, p53, p21).
  • Cell cycle analysis was performed using flow cytometry.

Main Results:

  • Interleukin-1 (IL-1) induced a time- and concentration-dependent increase in ceramide accumulation in IEC.
  • Neither IL-1 nor ceramide treatment resulted in apoptosis of IEC.
  • IL-1 and ceramide modulated apoptosis-related protein expression, increasing bcl-2 and decreasing bax and p21, while bcl-x and p53 remained unchanged.
  • A slight but significant increase in the G2/M phase of the cell cycle was observed.

Conclusions:

  • Ceramide accumulation, induced by IL-1 in IEC, does not directly trigger apoptosis.
  • The observed changes in apoptosis-related proteins and cell cycle suggest a potential role for ceramide in the enhanced tumorigenic activity observed in IBD patients.
Abstract

Related Concept Videos

IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...